Treatment for cryopyrin-associated periodic syndrome.
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002097:C-Reactive Protein / Q000378:metabolism; D002352:Carrier Proteins / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000235:genetics; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D010507:Periodicity; D000685:Serum Amyloid A Protein / Q000378:metabolism; D013577:Syndrome; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D002352:Carrier Proteins; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; D000685:Serum Amyloid A Protein; C541220:canakinumab; D002097:C-Reactive Protein